Unknown

Dataset Information

0

Pregabalin add-on for drug-resistant focal epilepsy.


ABSTRACT:

SUBMITTER: Panebianco M 

PROVIDER: S-EPMC8962962 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pregabalin add-on for drug-resistant focal epilepsy.

Panebianco Mariangela M   Bresnahan Rebecca R   Marson Anthony G AG  

The Cochrane database of systematic reviews 20220329


<h4>Background</h4>This is an updated version of the Cochrane Review last published in Issue 7, 2019; it includes two additional studies. Epilepsy is a common neurological disease that affects approximately 1% of the UK population. Approximately one-third of these people continue to have seizures despite drug treatment. Pregabalin is one of the newer antiepileptic drugs that has been developed to improve outcomes. In this review we summarised the current evidence regarding pregabalin when used a  ...[more]

Similar Datasets

| S-EPMC6614921 | biostudies-literature
| S-EPMC7059897 | biostudies-literature
| S-EPMC8647098 | biostudies-literature
| S-EPMC6517293 | biostudies-literature
| S-EPMC8094401 | biostudies-literature
| S-EPMC7083514 | biostudies-literature
| S-EPMC9298511 | biostudies-literature
| S-EPMC8919456 | biostudies-literature
| S-EPMC6437881 | biostudies-literature
| S-EPMC6804215 | biostudies-literature